Inborn Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Inborn Gene or Chromosome Alterations Pipeline Market Report Overview

The Inborn Gene or Chromosome Alterations pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       China

·       India

·       Israel

Key Regulatory Paths ·       510(k)

·       CE-IVD

·       PMA

·       ICAC

·       NMPA

Leading Companies ·       Aarhus University

·       AC-Gen Reading Life S.L.

·       Alexion Pharmaceuticals Inc

·       Amarantus Diagnostics Inc

·       Arrayit Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Inborn Gene or Chromosome Alterations Pipeline Market Segmentation by Territories

A few of the key territories associated with the Inborn Gene or Chromosome Alterations pipeline market are Europe, the United States, China, Japan, and Israel among others. As of September 2024, the US had the highest number of Inborn Gene or Chromosome Alterations pipeline products.

Inborn Gene or Chromosome Alterations Pipeline Market Analysis by Territories, September 2024 (%)

Inborn Gene or Chromosome Alterations Pipeline Market Analysis by Territories, September 2024 (%)

Buy the Full Report for More Territory Insights into the Inborn Gene or Chromosome Alterations Pipeline Market

Download a Free Report Sample

Inborn Gene or Chromosome Alterations Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the Inborn Gene or Chromosome Alterations pipeline products market are 510(k), CE-IVD, PMA, ICAC, and NMPA. As of September 2024, 510(k) was the most followed pathway for pipeline products in the Inborn Gene or Chromosome Alterations market.

Inborn Gene or Chromosome Alterations Pipeline Market Analysis by Regulatory Paths, As of September 2024 (%)

Inborn Gene or Chromosome Alterations Pipeline Market Analysis by Regulatory Paths, As of September 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Inborn Gene or Chromosome Alterations Pipeline Market

Download a Free Report Sample

Inborn Gene or Chromosome Alterations Pipeline Market – Competitive Landscape

A few of the key companies associated with the Inborn Gene or Chromosome Alterations pipeline market are Aarhus University, AC-Gen Reading Life S.L., Alexion Pharmaceuticals Inc, Amarantus Diagnostics Inc, and Arrayit Corp among others.

Aarhus University (Aarhus): Aarhus University (Aarhus) provides educational and research services. The university offers bachelor’s degree programmes, master’s degree programmes and PhD programmes in various disciplines. Its areas of academic interest comprise arts, science and technology, health and business and social sciences.

Arrayit Corp: Arrayit Corp engaged in research, developing and manufacturing proprietary life science and personalized medicine products. Its products include microarray scanners, microarrayers, deoxyribonucleic acid (DNA) microarrays, protein microarrays, microarray printing, microarray instruments, microarray substrate slides amplification and labeling kits and purification kits.

Inborn Gene or Chromosome Alterations Pipeline Market Analysis by Companies, As of September 2024
Inborn Gene or Chromosome Alterations Pipeline Market Analysis by Companies, As of September 2024Buy the Full Report for More Company Insights into the Inborn Gene or Chromosome Alterations Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Inborn Gene or Chromosome Alterations Pipeline Market Territories Outlook (2024)

  • Europe
  • The United States
  • India
  • China
  • Israel

Inborn Gene or Chromosome Alterations Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • PMA
  • ICAC
  • NMPA

Scope

This report provides:

  • Extensive coverage of the Inborn Gene or Chromosome Alterations devices under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Inborn Gene or Chromosome Alterations and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aarhus University
AC-Gen Reading Life S.L.
Alexion Pharmaceuticals Inc
Amarantus Diagnostics Inc
Arrayit Corp
Augusta University
Baylor College of Medicine
Boston Children's Hospital
CareDx Inc
Children's Hospital of Philadelphia
Cincinnati Children's Hospital Medical Center
Columbia University
Columbia University Fertility Center
Daan Gene Co Ltd
Decipher GenX, Inc.
Duke University
Epinex Diagnostics Inc
Firalis SAS
Fraunhofer Institute for Cell Therapy and Immunology
Fred Hutchinson Cancer Research Center
French National Institute of Health and Medical Research
Genentech USA Inc
Genomic Vision SA
genomiQa Pty Ltd
German Cancer Research Center
German Institute of Human Nutrition
Gilupi GmbH
Helmholtz Center Munich German Research Center for Health and Environment GmbH
Hummingbird Diagnostics GmbH
Interleukin Genetics Inc (Inactive)
Interpace Biosciences Inc
Johns Hopkins University
JS Genetics Inc
LS CancerDiag Ltd
Lucid Diagnostics Inc
Massachusetts Eye and Ear Infirmary
McGill University
Medical Research Council
Nanosphere Inc (Inactive)
National University of Singapore
Nel ASA
NewGene Ltd
Oxford Biodynamics Plc
Population Bio Inc
Precipio Inc
Predigen Inc
Prescient Medical Inc
Quest Diagnostics Inc
Revvity Inc
Sapien Biosciences
Scipher Medicine Corp
Seattle Children's Hospital
Seegene Inc
Sophia Genetics SA
Strand Life Sciences Pvt Ltd
SUNY Upstate Medical University
Suzhou Basecare Medical Co Ltd
TBG Diagnostics Ltd
Tel Aviv University
Transplant Genomics Inc
University of California San Diego
University of Central Florida
University of Colorado
University of Illinois at Chicago
University of Michigan
University of Pennsylvania
University of Pittsburgh
Vanderbilt University
Vanessa Biotech
Virginia Commonwealth University
VitaPath Genetics, Inc.

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Inborn Gene or Chromosome Alterations Overview

3 Products under Development

3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development

3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory

3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path

3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date

3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials

4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies

4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development

4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development

5 Inborn Gene or Chromosome Alterations Companies and Product Overview

5.1 Aarhus University Company Overview

5.1.1 Aarhus University Pipeline Products & Ongoing Clinical Trials Overview

5.2 AC-Gen Reading Life S.L. Company Overview

5.2.1 AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview

5.3 Alexion Pharmaceuticals Inc Company Overview

5.3.1 Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 Amarantus Diagnostics Inc Company Overview

5.4.1 Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Arrayit Corp Company Overview

5.5.1 Arrayit Corp Pipeline Products & Ongoing Clinical Trials Overview

5.6 Augusta University Company Overview

5.6.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview

5.7 Baylor College of Medicine Company Overview

5.7.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.8 Boston Children’s Hospital Company Overview

5.8.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.9 CareDx Inc Company Overview

5.9.1 CareDx Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Children’s Hospital of Philadelphia Company Overview

5.10.1 Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview

5.11 Cincinnati Children’s Hospital Medical Center Company Overview

5.11.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.12 Columbia University Company Overview

5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview

5.13 Columbia University Fertility Center Company Overview

5.13.1 Columbia University Fertility Center Pipeline Products & Ongoing Clinical Trials Overview

5.14 Daan Gene Co Ltd Company Overview

5.14.1 Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.15 Decipher GenX, Inc. Company Overview

5.15.1 Decipher GenX, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.16 Duke University Company Overview

5.16.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

5.17 Epinex Diagnostics Inc Company Overview

5.17.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.18 Firalis SAS Company Overview

5.18.1 Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview

5.19 Fraunhofer Institute for Cell Therapy and Immunology Company Overview

5.19.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview

5.20 Fred Hutchinson Cancer Research Center Company Overview

5.20.1 Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview

5.21 French National Institute of Health and Medical Research Company Overview

5.21.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview

5.22 Genentech USA Inc Company Overview

5.22.1 Genentech USA Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 Genomic Vision SA Company Overview

5.23.1 Genomic Vision SA Pipeline Products & Ongoing Clinical Trials Overview

5.24 genomiQa Pty Ltd Company Overview

5.24.1 genomiQa Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.25 German Cancer Research Center Company Overview

5.25.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview

5.26 German Institute of Human Nutrition Company Overview

5.26.1 German Institute of Human Nutrition Pipeline Products & Ongoing Clinical Trials Overview

5.27 Gilupi GmbH Company Overview

5.27.1 Gilupi GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.28 Helmholtz Center Munich German Research Center for Health and Environment GmbH Company Overview

5.28.1 Helmholtz Center Munich German Research Center for Health and Environment GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.29 Hummingbird Diagnostics GmbH Company Overview

5.29.1 Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.30 Interleukin Genetics Inc (Inactive) Company Overview

5.30.1 Interleukin Genetics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.31 Interpace Biosciences Inc Company Overview

5.31.1 Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.32 Johns Hopkins University Company Overview

5.32.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

5.33 JS Genetics Inc Company Overview

5.33.1 JS Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.34 LS CancerDiag Ltd Company Overview

5.34.1 LS CancerDiag Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.35 Lucid Diagnostics Inc Company Overview

5.35.1 Lucid Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.36 Massachusetts Eye and Ear Infirmary Company Overview

5.36.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview

5.37 McGill University Company Overview

5.37.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview

5.38 Medical Research Council Company Overview

5.38.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview

5.39 Nanosphere Inc (Inactive) Company Overview

5.39.1 Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.40 National University of Singapore Company Overview

5.40.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview

5.41 Nel ASA Company Overview

5.41.1 Nel ASA Pipeline Products & Ongoing Clinical Trials Overview

5.42 NewGene Ltd Company Overview

5.42.1 NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.43 Oxford Biodynamics Plc Company Overview

5.43.1 Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview

5.44 Population Bio Inc Company Overview

5.44.1 Population Bio Inc Pipeline Products & Ongoing Clinical Trials Overview

5.45 Precipio Inc Company Overview

5.45.1 Precipio Inc Pipeline Products & Ongoing Clinical Trials Overview

5.46 Predigen Inc Company Overview

5.46.1 Predigen Inc Pipeline Products & Ongoing Clinical Trials Overview

5.47 Prescient Medical Inc Company Overview

5.47.1 Prescient Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.48 Quest Diagnostics Inc Company Overview

5.48.1 Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.49 Revvity Inc Company Overview

5.49.1 Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview

5.50 Sapien Biosciences Company Overview

5.50.1 Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview

5.51 Scipher Medicine Corp Company Overview

5.51.1 Scipher Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview

5.52 Seattle Children’s Hospital Company Overview

5.52.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.53 Seegene Inc Company Overview

5.53.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview

5.54 Sophia Genetics SA Company Overview

5.54.1 Sophia Genetics SA Pipeline Products & Ongoing Clinical Trials Overview

5.55 Strand Life Sciences Pvt Ltd Company Overview

5.55.1 Strand Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.56 SUNY Upstate Medical University Company Overview

5.56.1 SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview

5.57 Suzhou Basecare Medical Co Ltd Company Overview

5.57.1 Suzhou Basecare Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.58 TBG Diagnostics Ltd Company Overview

5.58.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.59 Tel Aviv University Company Overview

5.59.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

5.60 Transplant Genomics Inc Company Overview

5.60.1 Transplant Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.61 University of California San Diego Company Overview

5.61.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

5.62 University of Central Florida Company Overview

5.62.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview

5.63 University of Colorado Company Overview

5.63.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

5.64 University of Illinois at Chicago Company Overview

5.64.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

5.65 University of Michigan Company Overview

5.65.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.66 University of Pennsylvania Company Overview

5.66.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview

5.67 University of Pittsburgh Company Overview

5.67.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.68 Vanderbilt University Company Overview

5.68.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

5.69 Vanessa Biotech Company Overview

5.69.1 Vanessa Biotech Pipeline Products & Ongoing Clinical Trials Overview

5.70 Virginia Commonwealth University Company Overview

5.70.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview

5.71 VitaPath Genetics, Inc. Company Overview

5.71.1 VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6 Inborn Gene or Chromosome Alterations- Recent Developments

6.1 Sep 10, 2024: Lucid Diagnostics to Host Symposium on Non-endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress

6.2 Sep 03, 2024: Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health

6.3 Aug 20, 2024: Lucid Diagnostics Announces Publication Of Analytical Validation Study Of Esoguard For Early Detection Of Esophageal Precancer And Cancer

6.4 Aug 08, 2024: Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard Precancer Testing Event

6.5 Aug 06, 2024: Lucid Diagnostics Announces Positive Data From ENVET-BE Clinical Utility Study Of Esoguard Esophageal Precancer Testing

6.6 Jul 26, 2024: BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping

6.7 Jul 23, 2024: Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume

6.8 Jul 02, 2024: Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard Esophageal Precancer Testing in a Screening Population

6.9 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024

6.10 Jun 28, 2024: ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders

6.11 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024

6.12 Jun 18, 2024: New Study Finds That Empowering Primary Care Providers with Data-Driven Cognitive Screening Tools Increases Identification of Cognitive Impairment

6.13 Jun 17, 2024: Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

6.14 Jun 12, 2024: 4,000th Firefighter Undergoes Lucid Diagnostics’ EsoGuard Esophageal Precancer Testing

6.15 Jun 04, 2024: Myriad Genetics Launches New Universal Plus Panel for Foresight Carrier Screen

6.16 May 13, 2024: Cardiff Oncology to Present at Upcoming Investor Conferences in May

6.17 May 07, 2024: Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference

6.18 May 02, 2024: Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of Esoguard Esophageal Precancer Testing

6.19 May 02, 2024: Yourbio Health Congratulates Myriad Genetics on One Million Sales of Sneakpeek Tests Enabled by Yourbio’s Virtually Painless Tap Technology

6.20 May 01, 2024: Natera to Report its First Quarter 2024 Results on May 9

6.21 Apr 23, 2024: GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

6.22 Apr 17, 2024: Billiontoone Mitigating Rhogam Shortage with Unity Fetal Rhd Non-invasive Prenatal Test

6.23 Mar 21, 2024: Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard Esophageal Precancer Testing in a Screening Population

6.24 Mar 20, 2024: Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference

6.25 Mar 19, 2024: Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance

6.26 Mar 19, 2024: Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024

6.27 Mar 14, 2024: GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

6.28 Mar 05, 2024: Sophia Genetics Q4 Revenues up 27 Percent

6.29 Feb 21, 2024: Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

6.30 Feb 16, 2024: Lucid Diagnostics Provides Update Regarding World Trade Center Health Program

6.31 Feb 08, 2024: Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors

6.32 Feb 08, 2024: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023

6.33 Jan 24, 2024: Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

6.34 Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024

6.35 Jan 03, 2024: Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

6.36 Dec 19, 2023: Invitae Slashes 235 Local Jobs

6.37 Dec 12, 2023: Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies

6.38 Dec 10, 2023: MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group

6.39 Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes

6.40 Nov 20, 2023: Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship

6.41 Nov 10, 2023: Lucid Diagnostics introduces new EsoGuard

2.0 DNA test

6.42 Nov 09, 2023: Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco

6.43 Nov 07, 2023: SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023 Record results on growth acceleration, significant improvement in operating loss and cash burn

6.44 Oct 31, 2023: Lucid Diagnostics Announces PREVENT and PREVENT-FF Registries of EsoGuardEsophageal Precancer Detection

6.45 Oct 30, 2023: Billiontoone Announces Clinical Outcomes Data for Unity Fetal Risk Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population

6.46 Oct 05, 2023: Illumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development

Inborn Gene or Chromosome Alterations – Pipeline Products by Territory

Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path

Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date

Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials

Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development

Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development

Aarhus University Pipeline Products & Ongoing Clinical Trials Overview

Cystic Fibrosis Urine Test – Product Status

Cystic Fibrosis Urine Test – Product Description

AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Hereditary Deafness – Product Status

Diagnostic Test – Hereditary Deafness – Product Description

Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

BeginNGS – Product Status

BeginNGS – Product Description

Alexion Pharmaceuticals Inc – Ongoing Clinical Trials Overview

BeginNGS – An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing

BeginNGS – Newborn Genomic Sequencing (BeginNGS) Prospective Pilot Study

Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – IFN-Beta Resistance – Product Status

Diagnostic Test – IFN-Beta Resistance – Product Description

Arrayit Corp Pipeline Products & Ongoing Clinical Trials Overview

PDx Pre-Symptomatic Test – Product Status

PDx Pre-Symptomatic Test – Product Description

Augusta University Pipeline Products & Ongoing Clinical Trials Overview

SUMO Gene Test – Type 1 Diabetes – Product Status

SUMO Gene Test – Type 1 Diabetes – Product Description

Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Rett Syndrome – Product Status

Diagnostic Assay – Rett Syndrome – Product Description

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Cystic Fibrosis – Product Status

Diagnostic Assay – Cystic Fibrosis – Product Description

Diagnostic Assay – Developmental Delay – Product Status

Diagnostic Assay – Developmental Delay – Product Description

CareDx Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

Diagnostic Test – Rheumatoid Arthritis – Product Status

Diagnostic Test – Rheumatoid Arthritis – Product Description

Diagnostic Test – Sjogren’s Syndrome – Product Status

Diagnostic Test – Sjogren’s Syndrome – Product Description

Diagnostic Test – Systemic Lupus Erythematosus – Product Status

Diagnostic Test – Systemic Lupus Erythematosus – Product Description

Children’s Hospital of Philadelphia Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Cornelia De Lange Syndrome – Product Status

Diagnostic Test – Cornelia De Lange Syndrome – Product Description

Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Biomarker Test – Biliary Atresia – Product Status

Diagnostic Biomarker Test – Biliary Atresia – Product Description

Columbia University Pipeline Products & Ongoing Clinical Trials Overview

Genetic Test – Schizophrenia – Product Status

Genetic Test – Schizophrenia – Product Description

Columbia University Fertility Center Pipeline Products & Ongoing Clinical Trials Overview

STORK Test – Product Status

STORK Test – Product Description

Daan Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Real Time PCR Kit – Beta-Mediterranean Anaemia – Product Status

Real Time PCR Kit – Beta-Mediterranean Anaemia – Product Description

Decipher GenX, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Chronic Fatigue Syndrome – Product Status

Diagnostic Test – Chronic Fatigue Syndrome – Product Description

Duke University Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Blood Test – Respiratory Infections – Product Status

Diagnostic Blood Test – Respiratory Infections – Product Description

Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Down Syndrome Screen Test – Product Status

Down Syndrome Screen Test – Product Description

Firalis SAS Pipeline Products & Ongoing Clinical Trials Overview

Prognostic miRNA Assay – Heart Failure – Product Status

Prognostic miRNA Assay – Heart Failure – Product Description

Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview

Multimodal Early Screening Test – Dyslexia – Product Status

Multimodal Early Screening Test – Dyslexia – Product Description

Fred Hutchinson Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview

FANCC Gene-Based Immuno-MRM Assay – Product Status

FANCC Gene-Based Immuno-MRM Assay – Product Description

FANCI Gene-Based Immuno-MRM Assay – Product Status

FANCI Gene-Based Immuno-MRM Assay – Product Description

French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Based Assay – Multiple Sclerosis – Product Status

Biomarker Based Assay – Multiple Sclerosis – Product Description

Genetic Diagnostic Kit – Bone Diseases – Product Status

Genetic Diagnostic Kit – Bone Diseases – Product Description

VLA-4 Based Assay – Duchenne Muscular Dystrophy – Product Status

VLA-4 Based Assay – Duchenne Muscular Dystrophy – Product Description

Genentech USA Inc Pipeline Products & Ongoing Clinical Trials Overview

Arbaclofen Companion Diagnostic Assay – Product Status

Arbaclofen Companion Diagnostic Assay – Product Description

Genomic Vision SA Pipeline Products & Ongoing Clinical Trials Overview

Spinal Muscular Atrophy Test – Product Status

Spinal Muscular Atrophy Test – Product Description

genomiQa Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

GulfDx – Product Status

GulfDx – Product Description

German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview

DGKA Based Assay – Radiation-induced Fibrosis – Product Status

DGKA Based Assay – Radiation-induced Fibrosis – Product Description

German Institute of Human Nutrition Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Obesity Associated Diabetes – Product Status

Diagnostic Test – Obesity Associated Diabetes – Product Description

Gilupi GmbH Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Down’s Syndrome – Product Status

Diagnostic Test – Down’s Syndrome – Product Description

Helmholtz Center Munich German Research Center for Health and Environment GmbH Pipeline Products & Ongoing Clinical Trials Overview

2-Gene Test – Product Status

2-Gene Test – Product Description

Diagnostic Test – Pre-Diabetes – Product Status

Diagnostic Test – Pre-Diabetes – Product Description

Hummingbird Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Multiple Sclerosis – Product Status

Diagnostic Test – Multiple Sclerosis – Product Description

Interleukin Genetics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Inherent Health Osteoarthritis Test – Product Status

Inherent Health Osteoarthritis Test – Product Description

Osteoporosis Risk Test – Product Status

Osteoporosis Risk Test – Product Description

Interpace Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

PathFinderTG – Pancreas (Supernatant) – Product Status

PathFinderTG – Pancreas (Supernatant) – Product Description

PathFinderTG – Ulcerative Colitis Supernatant – Product Status

PathFinderTG – Ulcerative Colitis Supernatant – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Biomarker Assay – Polycythemia Vera – Product Status

Biomarker Assay – Polycythemia Vera – Product Description

Diagnostic Kit – Psychiatric Disorder – Product Status

Diagnostic Kit – Psychiatric Disorder – Product Description

JS Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview

Dyslexia Predisposition Test – Product Status

Dyslexia Predisposition Test – Product Description

LS CancerDiag Ltd Pipeline Products & Ongoing Clinical Trials Overview

DiagMMR – Product Status

DiagMMR – Product Description

Lucid Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

EsoGuard Esophageal DNA Test – Product Status

EsoGuard Esophageal DNA Test – Product Description

Lucid Diagnostics Inc – Ongoing Clinical Trials Overview

EsoGuard Esophageal DNA Test – A Multicenter Case-control Study of the Efficacy of EsoGuard on Samples Collected Using EsoCheck, Versus Esophagogastroduodenoscopy, for the Diagnosis of Barrett’s Esophagus with and without Dysplasia, and for Esophageal Adenocarcinoma

EsoGuard Esophageal DNA Test – Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett’s Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial

EsoGuard Esophageal DNA Test – CLUE: CLinical Utility Study of EsoGuard on Samples Collected Using EsoCheck as a Triage Test for Endoscopy to Identify Barrett’s Esophagus (BE)

EsoGuard Esophageal DNA Test – Detection of Barrett s Esophagus in Patients Without Gastroesophageal Reflux Disease (GERD) Symptoms

EsoGuard Esophageal DNA Test – Genetic and Environmental Determinants of Barrett’s Esophagus and Esophageal Adenocarcinoma

EsoGuard Esophageal DNA Test – Non-endoscopic Esophageal Sampling to Detect Barrett’s Esophagus and Esophageal Cancer in Veterans

EsoGuard Esophageal DNA Test – Presence of Barrett’s Esophagitis in a Cohort of People With Eating Disorders Who Engage in Purging Behaviors: A Pilot Study

Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview

GEDi Test – Inherited Eye Disorders – Product Status

GEDi Test – Inherited Eye Disorders – Product Description

GEDi Test – Strabismus – Product Status

GEDi Test – Strabismus – Product Description

McGill University Pipeline Products & Ongoing Clinical Trials Overview

Genetic Marker Test – Recurrent Abortions – Product Status

Genetic Marker Test – Recurrent Abortions – Product Description

Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview

Epigenetic Test – Crohn’s Disease – Product Status

Epigenetic Test – Crohn’s Disease – Product Description

Genetic Test – Familial Hypercholesterolaemia – Product Status

Genetic Test – Familial Hypercholesterolaemia – Product Description

Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Verigene Processor SP System – Hemochromatosis (HFE) Nucleic Acid Test – Product Status

Verigene Processor SP System – Hemochromatosis (HFE) Nucleic Acid Test – Product Description

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview

Rapid Screening Assay – Fragile X Syndrome – Product Status

Rapid Screening Assay – Fragile X Syndrome – Product Description

Nel ASA Pipeline Products & Ongoing Clinical Trials Overview

AMYtect – Product Status

AMYtect – Product Description

NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview

Limb Girdle Muscular Dystrophy Test – Product Status

Limb Girdle Muscular Dystrophy Test – Product Description

Oxford Biodynamics Plc Pipeline Products & Ongoing Clinical Trials Overview

Companion Diagnostic Test – Amyotrophic Lateral Sclerosis – Product Status

Companion Diagnostic Test – Amyotrophic Lateral Sclerosis – Product Description

Companion Diagnostic Test – Corticobasal Degeneration – Product Status

Companion Diagnostic Test – Corticobasal Degeneration – Product Description

Companion Diagnostic Test – Dementia With Lewy Bodies – Product Status

Companion Diagnostic Test – Dementia With Lewy Bodies – Product Description

Companion Diagnostic Test – Diffuse Lewy Body Disease – Product Status

Companion Diagnostic Test – Diffuse Lewy Body Disease – Product Description

Companion Diagnostic Test – Frontotemporal Lobar Degeneration – Product Status

Companion Diagnostic Test – Frontotemporal Lobar Degeneration – Product Description

Companion Diagnostic Test – Multiple System Atrophy – Product Status

Companion Diagnostic Test – Multiple System Atrophy – Product Description

Companion Diagnostic Test – Osteoporosis – Product Status

Companion Diagnostic Test – Osteoporosis – Product Description

Companion Diagnostic Test – Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex – Product Status

Companion Diagnostic Test – Parkinsonism-Dementia-Amyotrophic Lateral Sclerosis Complex – Product Description

Companion Diagnostic Test – Progressive Supranuclear Palsy – Product Status

Companion Diagnostic Test – Progressive Supranuclear Palsy – Product Description

Companion Diagnostic Test – Sarcopenia – Product Status

Companion Diagnostic Test – Sarcopenia – Product Description

EpiSwitch Parkinson’s Disease Diagnostic Test – Product Status

EpiSwitch Parkinson’s Disease Diagnostic Test – Product Description

Population Bio Inc Pipeline Products & Ongoing Clinical Trials Overview

Genetic Test – Amyotrophic Lateral Sclerosis – Product Status

Genetic Test – Amyotrophic Lateral Sclerosis – Product Description

Genetic Test – Bipolar Disorder – Product Status

Genetic Test – Bipolar Disorder – Product Description

Genetic Test – Diabetes Mellitus – Product Status

Genetic Test – Diabetes Mellitus – Product Description

Genetic Test – Epilepsy – Product Status

Genetic Test – Epilepsy – Product Description

Genetic Test – Multiple Sclerosis – Product Status

Genetic Test – Multiple Sclerosis – Product Description

Genetic Test – Obesity – Product Status

Genetic Test – Obesity – Product Description

Genetic Test – Progressive Multifocal Leukoencephalopathy – Product Status

Genetic Test – Progressive Multifocal Leukoencephalopathy – Product Description

Genetic Test – Pulmonary Fibrosis – Product Status

Genetic Test – Pulmonary Fibrosis – Product Description

Genetic Test – Rheumatoid Arthritis – Product Status

Genetic Test – Rheumatoid Arthritis – Product Description

Genetic Test – Schizophrenia – Product Status

Genetic Test – Schizophrenia – Product Description

Precipio Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Parkinson’s Disease – Product Status

Diagnostic Test – Parkinson’s Disease – Product Description

Predigen Inc Pipeline Products & Ongoing Clinical Trials Overview

Predigen Autoimmune/Inflammatory Disease Test – Product Status

Predigen Autoimmune/Inflammatory Disease Test – Product Description

Prescient Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

DNA Guided Diagnostic Test – Cardiovascular Disease – Product Status

DNA Guided Diagnostic Test – Cardiovascular Disease – Product Description

DNA Guided Diagnostic Test – Diabetes – Product Status

DNA Guided Diagnostic Test – Diabetes – Product Description

DNA Guided Diagnostic Test – Obesity – Product Status

DNA Guided Diagnostic Test – Obesity – Product Description

Quest Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Genotyping Assay – Cystic Fibrosis – Product Status

Genotyping Assay – Cystic Fibrosis – Product Description

Genotyping Assay – Fragile X Syndrome – Product Status

Genotyping Assay – Fragile X Syndrome – Product Description

Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview

PerkinElmer Five-Plex qPCR Assay – Product Status

PerkinElmer Five-Plex qPCR Assay – Product Description

Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview

Genetic Testing Panel – Autism – Product Status

Genetic Testing Panel – Autism – Product Description

Genetic Testing Panel – Diabetes – Product Status

Genetic Testing Panel – Diabetes – Product Description

Genetic Testing Panel – Perinatal Disease – Product Status

Genetic Testing Panel – Perinatal Disease – Product Description

Scipher Medicine Corp Pipeline Products & Ongoing Clinical Trials Overview

PrismUC – Product Status

PrismUC – Product Description

Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Congenital Disorders – Product Status

Diagnostic Test – Congenital Disorders – Product Description

Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview

Allplex – Thrombosis Assay – Product Status

Allplex – Thrombosis Assay – Product Description

Sophia Genetics SA Pipeline Products & Ongoing Clinical Trials Overview

NGS Test – Cardiac Disease – Product Status

NGS Test – Cardiac Disease – Product Description

Strand Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Next-generation Sequencing Based Test – Hereditary Epilepsy – Product Status

Next-generation Sequencing Based Test – Hereditary Epilepsy – Product Description

Next-generation Sequencing Based Test – Hereditary PI – Product Status

Next-generation Sequencing Based Test – Hereditary PI – Product Description

SUNY Upstate Medical University Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Inflammatory Bowel Disease Risk – Product Status

Diagnostic Assay – Inflammatory Bowel Disease Risk – Product Description

Suzhou Basecare Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

PGT-SR Test Kit – Product Status

PGT-SR Test Kit – Product Description

WES Test Kit – Product Status

WES Test Kit – Product Description

TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

TBG Kit – Hereditary Genetic Disease – Product Status

TBG Kit – Hereditary Genetic Disease – Product Description

Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview

Blood Test – Genetic Disorders – Product Status

Blood Test – Genetic Disorders – Product Description

Transplant Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Heart Transplantation – Product Status

Diagnostic Test – Heart Transplantation – Product Description

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

Magnetic Nanosensor-Based miRNA Assay – Product Status

Magnetic Nanosensor-Based miRNA Assay – Product Description

University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview

hMRS Based Genomic Assay – Mycobacterium – Product Status

hMRS Based Genomic Assay – Mycobacterium – Product Description

PCR-Free Nucleic Acid Sequences Assay – Product Status

PCR-Free Nucleic Acid Sequences Assay – Product Description

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

CBS Gene Mutation Test – Product Status

CBS Gene Mutation Test – Product Description

University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Complicated Sarcoidosis – Product Status

Diagnostic Test – Complicated Sarcoidosis – Product Description

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – BRAF Negative Langerhans Cell Histiocytosis – Product Status

Diagnostic Test – BRAF Negative Langerhans Cell Histiocytosis – Product Description

Genetic Test – Neuron Disease – Product Status

Genetic Test – Neuron Disease – Product Description

University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Upper Respiratory Tract Infection – Product Status

Diagnostic Test – Upper Respiratory Tract Infection – Product Description

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

AuguryDx – Aneuploidy Assay – Product Status

AuguryDx – Aneuploidy Assay – Product Description

Biomarker Assay – Fetal Genetic Disease – Product Status

Biomarker Assay – Fetal Genetic Disease – Product Description

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Premature Birth – Product Status

Diagnostic Assay – Premature Birth – Product Description

Vanessa Biotech Pipeline Products & Ongoing Clinical Trials Overview

Microvillus Inclusion Disease Assay – Product Status

Microvillus Inclusion Disease Assay – Product Description

Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview

Gene Based Test – Risk of Premature Birth – Product Status

Gene Based Test – Risk of Premature Birth – Product Description

VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Spina Bifida – Product Status

Diagnostic Test – Spina Bifida – Product Description

Glossary

Figures

Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development

Inborn Gene or Chromosome Alterations – Pipeline Products by Territory

Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path

Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date

Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials

Frequently asked questions

Inborn Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Inborn Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Inborn Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Inborn Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.